LeadArtis participates in the first IACT scientific update meeting


The first IACT review meeting took place on November 17-18, 2014 in Frankfurt, Germany. Representatives of all partners, including management and scientific teams participated in the assembly.

The meeting focused on the work packages progress and the presentation of key capacities by each of the participants. LeadArtis competences involved the TrimerbodyTM technology for the generation, optimization and characterization of trivalent Immune Stimulating antibodies. Within the program, all participants presented the most relevant scientific data and technical aspects followed by discussion by the attendees.

The project coordination team set up the organizational action points and next meeting was scheduled for October 2015.

Latest News

LeadArtis to present at the final Chemostart pitching initiative in recognition of its highly innovative R&D activity
The Chemostart initiative (sponsored by the Chemo company) launched in 2018 as a call for...
LeadArtis project finalist of the Kaertor and J&J innovation award in recognition of its highly innovative R&D activity
The Kærtor Foundation together with Janssen (a Johnson & Johnson company) launched in 2018...
Leadartis discloses the project: ATTACK-Cancer immunotherapy by bispecific antibodies that recruit T lymphocytes

LeadArtis is pleased to announce its participation as coordinator of the ATTACK project (Cancer...